Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 30, 2026 03:00 ET | Source: Cure 4 The Kids Foundation

American Idol, The Voice Finalists Lend Their Voices To Special Holiday Anthem Benefiting Childhood Cancer Warriors

Las Vegas, June 30, 2026 (GLOBE NEWSWIRE) -- American Idol Finalists Mackenzie Sol, Drew Ryn, Maryjo Young, Amanda Barise, and Samoan Silk along with former member of Why Don’t We, Jonah Marais, The...
June 29, 2026 19:06 ET | Source: Arcutis Biotherapeutics, Inc.

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
June 29, 2026 17:17 ET | Source: Zoumalan, MD FACS Inc.

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Beverly Hills, CA, June 29, 2026 (GLOBE NEWSWIRE) -- Zoumalan, MD FACS Inc. today announced its trademarked Natural Looking Blepharoplasty® approach to eyelid rejuvenation as growing demand for...
June 29, 2026 16:54 ET | Source: Fisher House Foundation

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

Rockville, MD, June 29, 2026 (GLOBE NEWSWIRE) -- For 22 consecutive years, Charity Navigator has awarded Fisher House Foundation 4 out of 4 stars and has also given the Foundation a perfect score of...
June 29, 2026 16:30 ET | Source: Praxis Precision Medicines, Inc.

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

FDA sets updated PDUFA date of December 27, 2026 BOSTON, June 29, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system (CNS)...
June 29, 2026 16:05 ET | Source: Abivax

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance...
June 29, 2026 16:05 ET | Source: Abivax

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité ...
June 29, 2026 16:05 ET | Source: Gain Therapeutics, Inc.

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA’s decision follows positive Phase 1 results for GT-02287 in both healthy...
June 29, 2026 15:02 ET | Source: Acorn Health

Acorn Health Expands Autism Diagnostic Evaluations in Florida

Acorn Health has expanded autism diagnostic services in Florida, with comprehensive diagnostic evaluations now available in Tampa and Orlando.
June 29, 2026 13:57 ET | Source: Diabetes Canada

Canada's first "talking statue" debuts at Banting House this summer—hear from Sir Frederick Banting himself

London, Ontario, June 29, 2026 (GLOBE NEWSWIRE) -- This summer Banting House National Historic Site is launching Canada's first interactive "talking statue," bringing the story of Sir Frederick...